Literature DB >> 26774228

Decreased bioavailability of nitric oxide in aorta from ovariectomized senescent mice. Role of cyclooxygenase.

Xavier Vidal-Gómez1, Susana Novella1, Isabel Pérez-Monzó1, Manel Garabito2, Ana Paula Dantas2, Gloria Segarra1, Carlos Hermenegildo1, Pascual Medina3.   

Abstract

This study investigates the effects of aging and/or ovariectomy on vascular reactivity to thromboxane A2 (TXA2) receptor stimulation with U46619, and the modulation by nitric oxide (NO) and cyclooxygenase (COX) in aorta from female senescence-accelerated mice (SAMP8) and from senescence resistant mice (SAMR1). Five-month-old female SAMR1 and SAMP8 were divided into three groups: sham-operated, ovariectomized and ovariectomized plus estradiol. Twenty-eight days after surgery, thoracic aortic rings were mounted for isometric recording of tension and concentration-response curves for U46619 (10(-10)-3 × 10(-7) M) were performed in the absence and in the presence of the NO synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME, 10(-4) M) and/or COX inhibitor indomethacin (10(-5)M). Vascular superoxide production was detected by dihydroethidium staining on sections of thoracic aorta. NO bioavailability in response to U46619 was suppressed by estrogen withdrawn in young and senescent mice and was restored by the administration of estradiol. In the presence of indomethacin, contractions to U46619 decreased in all groups indicating an aging- and estrogen-dependent modulation of contractile prostanoids. The simultaneous incubation of L-NAME and indomethacin did not change the maximal responses and sensitivities to TXA2 in any group in comparison with untreated aortic segments. The superoxide generation induced by TXA2 was greater in aorta from SAMP8 than in SAMR1. Moreover, in ovariectomized groups superoxide production was further increased and treatment with 17β-estradiol reverted the effects of the ovariectomy. Inhibition of COX with indomethacin prevented the U46619-induced increase in superoxide formation. Our results indicate that NO bioavailability in response to TP receptor activation is both estrogen- and aging-dependent. TXA2 induced contractions are partially mediated by COX activation. Both aging and ovariectomy enhanced COX-dependent component of the TXA2-induced contraction. It is noteworthy that in the absence of estrogen, COX inhibition induces an increase of NO bioavailability. Therefore, in senescent female mice with an experimental menopause, TP-receptor stimulation is responsible for COX activation and enhanced superoxide generation, which may result in reduced NO bioavailability. These effects were reversed by estrogen administration.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Estrogen; Experimental menopause; Nitric oxide; Prostanoids; Senescence-accelerated mice; Vascular reactivity

Mesh:

Substances:

Year:  2016        PMID: 26774228     DOI: 10.1016/j.exger.2016.01.006

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  9 in total

1.  Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells.

Authors:  Daniel Pérez-Cremades; Carlos Bueno-Betí; José Luis García-Giménez; José Santiago Ibañez-Cabellos; Carlos Hermenegildo; Federico V Pallardó; Susana Novella
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

Review 2.  Uric Acid for Cardiovascular Risk: Dr. Jekyll or Mr. Hide?

Authors:  Cristina Vassalle; Annamaria Mazzone; Laura Sabatino; Clara Carpeggiani
Journal:  Diseases       Date:  2016-02-26

Review 3.  Role of miRNA in the Regulatory Mechanisms of Estrogens in Cardiovascular Ageing.

Authors:  Daniel Pérez-Cremades; Ana Mompeón; Xavier Vidal-Gómez; Carlos Hermenegildo; Susana Novella
Journal:  Oxid Med Cell Longev       Date:  2018-12-20       Impact factor: 6.543

4.  Influence of Active Exposure to Tobacco Smoke on Nitric Oxide Status of Pregnant Women.

Authors:  Magdalena Chełchowska; Jadwiga Ambroszkiewicz; Joanna Gajewska; Joanna Mazur; Leszek Lewandowski; Marzanna Reśko-Zachara; Tomasz M Maciejewski
Journal:  Int J Environ Res Public Health       Date:  2018-12-03       Impact factor: 3.390

5.  Late Onset of Estrogen Therapy Impairs Carotid Function of Senescent Females in Association with Altered Prostanoid Balance and Upregulation of the Variant ERα36.

Authors:  Tiago Januário Costa; Francesc Jiménez-Altayó; Cinthya Echem; Eliana Hiromi Akamine; Rita Tostes; Elisabet Vila; Ana Paula Dantas; Maria Helena Catelli de Carvalho
Journal:  Cells       Date:  2019-10-08       Impact factor: 6.600

6.  The imbalance in the aortic ceramide/sphingosine-1-phosphate rheostat in ovariectomized rats and the preventive effect of estrogen.

Authors:  Yao Li; Wei Zhang; Junlei Li; Yanrong Sun; Qiyue Yang; Sinan Wang; Xiaofeng Luo; Wenjuan Wang; Ke Wang; Wenpei Bai; Haicheng Zhang; Lihua Qin
Journal:  Lipids Health Dis       Date:  2020-05-19       Impact factor: 3.876

Review 7.  miRNA as a New Regulatory Mechanism of Estrogen Vascular Action.

Authors:  Daniel Pérez-Cremades; Ana Mompeón; Xavier Vidal-Gómez; Carlos Hermenegildo; Susana Novella
Journal:  Int J Mol Sci       Date:  2018-02-06       Impact factor: 5.923

Review 8.  Approaching Sex Differences in Cardiovascular Non-Coding RNA Research.

Authors:  Amela Jusic; Antonio Salgado-Somoza; Ana B Paes; Francesca Maria Stefanizzi; Núria Martínez-Alarcón; Florence Pinet; Fabio Martelli; Yvan Devaux; Emma Louise Robinson; Susana Novella
Journal:  Int J Mol Sci       Date:  2020-07-10       Impact factor: 6.208

Review 9.  Sex steroids receptors, hypertension, and vascular ageing.

Authors:  Paul J Connelly; Helen Casey; Augusto C Montezano; Rhian M Touyz; Christian Delles
Journal:  J Hum Hypertens       Date:  2021-07-06       Impact factor: 3.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.